Return to search

Pre-clinical evaluation of Bcl-2 inhibitor ABT-737 in small cell lung cancer

The evasion of apoptosis is a common feature of various malignancies and often depends on the overexpression of Bcl-2 family antiapoptotic proteins. Resistance to chemotherapy and radiotherapy is promoted because these tumour cells have a higher threshold for apoptosis-promoting signals than their normal cell counterparts. This has lead to the development of BH3 mimetic compounds that target the survival proteins of the Bcl-2 family.

Identiferoai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:506239
Date January 2009
CreatorsMicha, Dimitra
PublisherUniversity of Manchester
Source SetsEthos UK
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation

Page generated in 0.0018 seconds